Patents Assigned to QUOGUE IP HOLDINGS LLC
  • COMBINATION OF A BTK INHIBITOR AND AN MDM2 INHIBITOR FOR CANCER TREATMENT
    Publication number: 20220387434
    Abstract: Therapeutic methods and pharmaceutical compositions for treating a cancer, including a B cell hematological malignancy selected from the group consisting of chronic lymphocytic leukemia (CLL), small lymphocytic leukemia (SLL), non-Hodgkin's lymphoma (NHL), diffuse large B cell lymphoma (DLBCL), follicular lymphoma (FL), mantle cell lymphoma (MCL), Hodgkin's lymphoma, B cell acute lymphoblastic leukemia (B-ALL), Burkitt's lymphoma, and Waldenström's macroglobulinemia (WM).
    Type: Application
    Filed: November 13, 2020
    Publication date: December 8, 2022
    Applicant: QUOGUE IP HOLDINGS LLC
    Inventor: Wayne Rothbaum